Pages that link to "Q70166727"

The following pages link to Serum antibody responses to individual viral polypeptides in human rotavirus infections (Q70166727):

Displaying 43 items.

• Humoral immune responses to VP4 and its cleavage products VP5* and VP8* in infants vaccinated with rhesus rotavirus (Q31160938) (← links)
• Antibody-secreting cell responses to rotavirus proteins in gnotobiotic pigs inoculated with attenuated or virulent human rotavirus (Q33973105) (← links)
• Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo. (Q34291161) (← links)
• The antigenic diversity of rotaviruses: significance to epidemiology and vaccine strategies. (Q34553936) (← links)
• Recombinant monovalent llama-derived antibody fragments (VHH) to rotavirus VP6 protect neonatal gnotobiotic piglets against human rotavirus-induced diarrhea (Q34711833) (← links)
• Identification of a T-helper cell epitope on the rotavirus VP6 protein (Q35874990) (← links)
• Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine (Q35941247) (← links)
• Quantification of systemic and local immune responses to individual rotavirus proteins during rotavirus infection in mice (Q36535017) (← links)
• Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture (Q36688358) (← links)
• NS35 and not vp7 is the soluble rotavirus protein which binds to target cells (Q36799427) (← links)
• Immunization with baculovirus-expressed VP4 protein passively protects against simian and murine rotavirus challenge (Q36803819) (← links)
• Rabbit model of rotavirus infection (Q36866742) (← links)
• Rotavirus gene structure and function (Q37055891) (← links)
• Analysis of homotypic and heterotypic serum immune responses to rotavirus proteins following primary rotavirus infection by using the radioimmunoprecipitation technique (Q37064328) (← links)
• Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccine (Q37135255) (← links)
• Homotypic serum antibody responses to rotavirus proteins following primary infection of young children with serotype 1 rotavirus (Q37188471) (← links)
• Homotypic and heterotypic serological responses to rotavirus neutralization epitopes in immunologically naive and experienced animals. (Q37245966) (← links)
• Non-structural protein NSP2 induces heterotypic antibody responses during primary rotavirus infection and reinfection in children (Q37370235) (← links)
• Correlates of protection against human rotavirus disease and the factors influencing protection in low-income settings (Q38281298) (← links)
• Complete genome characterization of recent and ancient Belgian pig group A rotaviruses and assessment of their evolutionary relationship with human rotaviruses (Q38389360) (← links)
• Rotavirus VP6 preparations as a non-replicating vaccine candidates. (Q38506308) (← links)
• Characterization of a genetically heterogeneous porcine rotavirus C, and other viruses present in the fecal virome of a non-diarrheic Belgian piglet (Q38866731) (← links)
• A time-resolved immunoassay to measure serum antibodies to the rotavirus VP6 capsid protein (Q39617559) (← links)
• Intracellular manipulation of disulfide bond formation in rotavirus proteins during assembly (Q40038604) (← links)
• Polypeptide specificity of antiviral serum antibodies in children naturally infected with human rotavirus (Q40101068) (← links)
• Lack of cosegregation of the subgroup II antigens on genes 2 and 6 in porcine rotaviruses (Q40107581) (← links)
• Antibody response to serotype-specific and cross-reactive neutralization epitopes on VP4 and VP7 after rotavirus infection or vaccination (Q40211369) (← links)
• Rotavirus capsid VP6 tubular and spherical nanostructures act as local adjuvants when co-delivered with norovirus VLPs. (Q40243520) (← links)
• The VP6 protein of rotavirus interacts with a large fraction of human naive B cells via surface immunoglobulins (Q40276522) (← links)
• Immunogenicity and protective efficacy of a formalin-inactivated rotavirus vaccine combined with lipid adjuvants (Q40676887) (← links)
• Biosynthesis and morphogenesis of group C rotavirus in swine testicular cells (Q41585057) (← links)
• Serum IgA immune response to individual rotavirus polypeptides in young children with rotavirus infection (Q44081274) (← links)
• The endoplasmic reticulum-associated VP7 of rotavirus is targeted to axons and dendrites in polarized neurons. (Q44675221) (← links)
• Viral proteins VP2, VP6, and NSP2 are strongly precipitated by serum and fecal antibodies from children with rotavirus symptomatic infection (Q47699669) (← links)
• Serologic responses by immunoblot following natural infection with rotavirus serotypes G1 and G4 in children (Q47699682) (← links)
• Molecular characterisation of rotavirus strains detected during a clinical trial of the human neonatal rotavirus vaccine (RV3-BB) in Indonesia (Q58726950) (← links)
• Serological responses to rotavirus NSP2 following administration of RV3-BB human neonatal rotavirus vaccine (Q59349252) (← links)
• Development of T cell immunity to norovirus and rotavirus in children under five years of age (Q64084491) (← links)
• Antibody prevalence and specificity to group C rotavirus in Swedish sera (Q64131124) (← links)
• Lack of serum immune response to Blastocystis hominis (Q69908050) (← links)
• Encapsulation of rotavirus into poly(lactide-co-glycolide) microspheres (Q77760328) (← links)
• Sero-epidemiological study of the rotavirus VP8* protein from different P genotypes in Valencia, Spain (Q94570518) (← links)
• Advances in the Development of Antiviral Compounds for Rotavirus Infections (Q114397730) (← links)